Dr. Joseph N. Pace, MD
Internal Medicine (Internal Medicine Physician)
- Medicare participating
At a glance
- Medical school
- Hahnemann University College of Medicine (1990)
- Years since graduation
- 36
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 2,179
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1990Medical school: Hahnemann University College of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
FL license ME73506 -
Cardiovascular Disease Physician
FL license ME73506 -
Clinical Cardiac Electrophysiology Physician
FL license ME0073506
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Lakewood Ranch Medical Center Bradenton, FL
- HCA Florida Blake Hospital Bradenton, FL
- Manatee Memorial Hospital Bradenton, FL
- HCA Florida Sarasota Doctors Hospital Sarasota, FL
- HCA Florida Englewood Hospital Englewood, FL
Medical groups
- Arcadia Medical Associates PA (19 clinicians)
- Ekg PAnel of Blake (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,179
- Services billed
- 5,423
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,965 | 1,452 |
| Established patient office or other outpatient visit, 30-39 minutes | 613 | 395 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 340 | 64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 241 | 229 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 224 | 40 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 209 | 102 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 168 | 84 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 166 | 107 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 161 | 157 |
| Established patient office or other outpatient visit, 20-29 minutes | 153 | 127 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Bradenton, FL | 225 |
| Atorvastatin Calcium Other prescribers in Bradenton, FL | 178 |
| Xarelto (rivaroxaban) Other prescribers in Bradenton, FL | 152 |
| Rosuvastatin Calcium Other prescribers in Bradenton, FL | 122 |
| Eliquis (apixaban) Other prescribers in Bradenton, FL | 107 |
| Lisinopril Other prescribers in Bradenton, FL | 100 |
| Hydrochlorothiazide Other prescribers in Bradenton, FL | 100 |
| Metoprolol Succinate Other prescribers in Bradenton, FL | 85 |
| Furosemide Other prescribers in Bradenton, FL | 74 |
| Carvedilol Other prescribers in Bradenton, FL | 73 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 24 companies reported 145 payments worth $12,836 in total to this clinician.
| Cvrx, Inc. | $6,200 |
|---|---|
| Abbott Laboratories | $2,913 |
| Boston Scientific Corporation | $1,633 |
| Alnylam Pharmaceuticals Inc. | $239 |
| Pfizer Inc. | $220 |
| Corvista Health, Inc. | $169 |
| Biosense Webster, Inc. | $164 |
| Medtronic, Inc. | $156 |
| Food and Beverage | $5,086 |
|---|---|
| Consulting Fee | $4,200 |
| Travel and Lodging | $3,550 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Cvrx, Inc. Feb 20, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $1,400 |
| Cvrx, Inc. Apr 2, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $1,400 |
| Cvrx, Inc. Dec 17, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $1,400 |
| Boston Scientific Corporation Apr 6, 2025 | Travel and Lodging INGEVITY+ · Ingevity+_CRM · travel to Arden Hills, MN · in-kind | $847 |
| Abbott Laboratories Feb 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Nashville, TN · in-kind | $731 |
| Abbott Laboratories Sep 18, 2025 | Travel and Lodging AMPLATZER AMULET · Structural Heart · travel to Denver, CO · in-kind | $412 |
| Abbott Laboratories Sep 19, 2025 | Travel and Lodging AMPLATZER AMULET · Structural Heart · travel to Denver, CO · in-kind | $333 |
| Cvrx, Inc. Mar 17, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to New York, NY | $266 |
| Boston Scientific Corporation Apr 6, 2025 | Travel and Lodging INGEVITY+ · Ingevity+_CRM · travel to Arden Hills, MN · in-kind | $252 |
| Cvrx, Inc. Apr 21, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to New York, NY | $227 |
All 15 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Cvrx, Inc. Dec 17, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $1,400 |
| Abbott Laboratories Sep 19, 2025 | Travel and Lodging AMPLATZER AMULET · Structural Heart · travel to Denver, CO · in-kind | $333 |
| Abbott Laboratories Sep 18, 2025 | Travel and Lodging AMPLATZER AMULET · Structural Heart · travel to Denver, CO · in-kind | $412 |
| Cvrx, Inc. Apr 21, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to New York, NY | $227 |
| Boston Scientific Corporation Apr 7, 2025 | Travel and Lodging INGEVITY+ · Ingevity+_CRM · travel to Arden Hills, MN · in-kind | $18.46 |
| Boston Scientific Corporation Apr 6, 2025 | Travel and Lodging INGEVITY+ · Ingevity+_CRM · travel to Arden Hills, MN · in-kind | $847 |
| Boston Scientific Corporation Apr 6, 2025 | Travel and Lodging INGEVITY+ · Ingevity+_CRM · travel to Arden Hills, MN · in-kind | $252 |
| Cvrx, Inc. Apr 2, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $1,400 |
| Cvrx, Inc. Apr 2, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Fort Myers, FL | $140 |
| Cvrx, Inc. Mar 17, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to New York, NY | $266 |
| Cvrx, Inc. Feb 20, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $1,400 |
| Abbott Laboratories Feb 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Nashville, TN · in-kind | $731 |
| Abbott Laboratories Feb 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Nashville, TN · in-kind | $187 |
| Abbott Laboratories Feb 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Nashville, TN · in-kind | $127 |
| Abbott Laboratories Feb 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Nashville, TN · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $35,920 in research payments for these studies, mostly to the institutions running them.
- Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
Cvrx, Inc. · Terminated · NCT04502316
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.